Global Molecular Diagnostics Market - Technologies, Products, Applications and End-Use Sectors

Report
554 Pages
June 2020
Region: Global
Industry Experts
ID: 5093791

Report Synopsis

Amid COVID-19 outbreak, the global market for Molecular Diagnostics has created mixed opportunities for manufacturers all over the world. While some of the application segments, such as infectious diseases, is projected to record the highest growth during the pandemic period of 2019-2022, but other applications such as oncology, etc. are estimated to face a reduction in demand during the same period.

Global Molecular Diagnostics market has generated a revenue of US$10.85 billion in 2019 and is estimated to be just over US$15 billion in 2020. During 2019 to 2022 period, which is said to be influenced by the Covid-19 pandemic, the Infectious Diseases segment is anticipated to gain rapid demand, growing at a robust CAGR of 14.9%. Infectious Diseases segment, in which Covid-19 testing is a part, is estimated to generate an extra revenue of US$3.8 billion globally in 2020 compared to 2019.

Research Findings & Coverage

This most comprehensive report on Molecular Diagnostics, analyzes the global market with respect to technologies, product types, applications and end-use sectors
Molecular Diagnostics’ market size is estimated in this report by product types, technologies, applications and end-use sectors across all major countries
Molecular Diagnostics Take the Center Stage in COVID-19 Testing
COVID-19 Pandemic Takes Korean Testing Kits Demand to New Heights
New CRISPR-Based Technology Developed for COVID-19 Identification
Molecular Diagnostics of Infectious Diseases Undergo Dramatic Advancements
Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
Major companies profiled – 46
The industry guide includes the contact details for 169 companies

Product Outline
The report analyzes the market for the following key technologies of Molecular Diagnostics:

PCR
Sequencing
Hybridization
Other

The market for key product types of Molecular Diagnostics studied in this report comprise the following:

Reagents & Consumables
Instruments
Software & Services

The market for major applications of Molecular Diagnostics explored in this report comprise the following:

Infectious Diseases
Oncology
Blood Testing
Genetic Testing
Prenatal Testing
Other

The report analyzes the market for the following end-use sectors of Molecular Diagnostics:

Hospitals & Diagnostics Labs
Research Institutes & Universities
Other

Analysis Period, Units and Growth Rates

The report reviews, analyzes and projects the global Molecular Diagnostics market for the period 2017-2026 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2019 through 2026

Geographic Coverage

North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Italy, Spain and Rest of Europe)
Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
Rest of World (Brazil, Argentina, Israel, and Other Countries)

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION
1.1 Product Outline
1.1.1 Significance of Diagnostics
1.1.2 Molecular Diagnostics Defined
1.1.2.1 Molecules Detected Via Molecular Diagnostics
1.1.2.1.1 Chromosome
1.1.2.1.2 DNA
1.1.2.1.3 RNA
1.1.2.1.4 Genes
1.1.2.1.5 Proteins
1.1.2.2 A Historic Review of Molecular Diagnostics
1.1.2.3 Basic Steps Involved in Molecular Diagnostics Assay
1.1.2.4 Sample Collection and Storage
1.1.2.5 Uses of Molecular Diagnostics
1.1.2.6 Technologies of Molecular Diagnostics
1.1.2.6.1 Polymerase Chain Reaction (PCR)
1.1.2.6.1.1 Real-Time PCR
1.1.2.6.1.2 Reverse Transcription-PCR
1.1.2.6.2 Sequencing
1.1.2.6.3 Hybridization
1.1.2.6.3.1 Nucleic Acid Hybridization
1.1.2.6.3.2 In situ Hybridization
1.1.2.6.3.3 FISH
1.1.2.6.4 Immunohistochemistry
1.1.2.6.5 NAAT- Nucleic Acid Amplification Technologies
1.1.2.6.5.1 Ligase chain reaction (LCR)
1.1.2.6.5.2 Strand Displacement Amplification (SDA)
1.1.2.6.5.3 Rolling Circle Amplification
1.1.2.6.5.4 Multiplex Ligation-Dependent Probe Amplification (MLPA)
1.1.2.6.5.5 Other
1.1.2.6.6 Microarray
1.1.2.6.6.1 DNA microarrays
1.1.2.6.6.2 Protein or Peptide Chips
1.1.2.6.7 Nanotechnology
1.1.2.6.7.1 Gold Nanoparticles
1.1.2.6.7.2 Quantum Dots
1.1.2.6.7.3 Magnetic Nanoparticles
1.1.2.6.7.4 Nanobiosensors
1.1.2.6.7.5 Sensing of Phage-Triggered Ion Cascade (SEPTIC)
1.1.2.7 Product Types of Molecular Diagnostics
1.1.2.7.1 Reagents and Consumables
1.1.2.7.1.1 Probes
1.1.2.7.1.1.1 DNA probes
1.1.2.7.1.1.2 Genetic probes
1.1.2.7.1.1.3 Molecular Probes
1.1.2.7.1.2 Primers
1.1.2.7.1.3 PCR Reagents
1.1.2.7.2 Instruments
1.1.2.7.3 Software & Services
1.1.2.8 Applications of Molecular Diagnostics
1.1.2.8.1 Infectious Diseases
1.1.2.8.1.1 Hospital Acquired Infections
1.1.2.8.1.2 Blood Infections
1.1.2.8.1.3 Respiratory Tract Infection
1.1.2.8.1.4 Influenza virus Detection
1.1.2.8.2 Oncology
1.1.2.8.2.1 Circulating Tumor Cells or DNA Diagnosis
1.1.2.8.2.2 Risk Assessment
1.1.2.8.2.3 Diagnosis and Differential Diagnosis
1.1.2.8.2.4 Prognosis
1.1.2.8.2.5 Anticipation of Therapeutic Response
1.1.2.8.2.6 Monitorization of Therapeutic Response
1.1.2.8.2.7 Monitoring Recurrence in Asymptomatic Cancer Patients
1.1.2.8.3 Blood Testing
1.1.2.8.3.1 HIV/HCV Testing
1.1.2.8.4 Genetic Testing
1.1.2.8.5 Prenatal Testing
1.1.2.8.5.1 Types of Prenatal Tests
1.1.2.8.5.1.1 Screening Test
1.1.2.8.5.1.2 Diagnostics Test Chorionic villus sampling - (CVS) Amniocentesis
1.1.2.8.6 Agriculture Applications
1.1.2.8.7 Veterinary Application
1.1.2.8.8 Dairy Application
1.1.2.9 End-Use Applications of Molecular Diagnostics
1.1.2.9.1 Hospitals and Diagnostics Labs
1.1.2.9.2 Research Institutes and Universities
1.1.2.9.3 Other
1.1.2.9.3.1 Blood Banks

2. KEY MARKET TRENDS
2.1 Speedier Results Promised by New Test for COVID-19
2.2 COVID-19 Pandemic Takes Korean Testing Kits Demand to New Heights
2.3 New CRISPR-Based Technology Developed for COVID-19 Identification
2.4 Tracing Incidences of Salmonella Food-Poisoning to be Enhanced through New DNA Test
2.5 Molecular Diagnostics of Infectious Diseases Undergo Dramatic Advancements
2.6 Monitoring Treatment of Residual Disease in High-Risk Neuroblastoma Patients Facilitated by Innovative Method
2.7 Time for Diagnosing Sepsis Shortened Significantly Via Novel Next-Generation Sequencing Technique
2.8 Monitoring Antimalarial Drug Resistance Made Easier by Blood Drop Assay
2.9 Silicon Based-Nanostructured Microfluidics - A Novel Molecular Diagnostic Technology for Fetal Aneuploidy
2.10 Creation of Novel and Powerful Adaptive PCR Technique for Rapid Genetic Analysis
2.11 Web Tool Foretells Phenotypes Using little DNA Sample
2.12 Emergence of CRISPR as a Novel Molecular Diagnostic Tool

3. KEY GLOBAL PLAYERS

Abbott Diagnostics (United States)
Agendia NV (The Netherlands)
Agilent Technologies, Inc. (United States)
Becton, Dickinson and Company (United States)
Biomérieux SA (France)
Bio-Rad Laboratories, Inc. (United States)
Danaher Corporation (United States)
DNA Diagnostics Center (United States)
Elitechgroup (France)
Exact Sciences Corporation (United States)
F. Hoffmann-La Roche Ag (Switzerland)
Genmark Diagnostics, Inc. (United States)
Global Life Sciences Solutions USA LLC (Cytiva) (United States)
Grifols International, S.A. (Spain)
Hologic, Inc. (United States)
Illumina, Inc. (United States)
Kaneka Eurogentec S.A. (Belgium)
Laboratory Corporation of America® Holdings (United States)
Luminex Corporation (United States)
Merck KGaA (Merck Millipore) (United States)
Myriad Genetics, Inc. (United States)
Origene Technologies, Inc. (United States)
Ortho Clinical Diagnostics (United States)
Oxford Gene Technology (United Kingdom)
Perkinelmer Inc. (United States)
Promega Corporation (United States)
Qiagen N.V. (The Netherlands)
Savyon Diagnostics (Israel)
Seegene Inc. (South Korea)
Siemens Healthcare GmbH (Germany)
Sorenson Genomics, LLC (United States)
Sysmex Inostics GmbH (Germany)
Thermo Fisher Scientific Inc. (United States)
Transgenomic Inc. (United States)
Wuxi Nextcode (China)

4. KEY BUSINESS TRENDS

Roche’s Elecsys® Anti-SARS-CoV-2 Antibody Test Receives FDA Emergency Use Authorization
Grifols’ Molecular Test to Detect SARS-CoV-2 Virus Developed
Merck’s Introductory CRISPR-Cas9 Technology Awarded US Patents
FDA Approval for Myriad's BRACAnalysis CDx® and myChoice CDx® Tests for Use as a Companion Diagnostic for Lynparza® in Patients with mCRPC and Advanced Ovarian Cancer
Global Shipment of Siemens Healthineers SARS-CoV-2 Total Antibody Test
CE Mark for Ortho's Second COVID-19 Antibody Test
CE Mark Approval for TBG Diagnostics' COVID-19 Nucleic Acid and Antibody Rapid Test Kits
Open Philanthropy Funded $7.5 Million to Launch Sherlock Innovation Lab to Develop COVID-19 Diagnostics
Bosch and BioGX Joined Forces to Develop and Commercialize New Tests for Vivalytic Platform
Bioneer Flooded with Orders for Its Proprietary RT-PCR Molecular Diagnostic Equipment for COVID-19
Thermo Fisher Scientific Partners with WuXi Diagnostics and Mayo Clinic to Develop Total Antibodies Test for COVID-19
Export of 10 Million Tests of Seegene's COVID-19 Test Kits to PAHO / WHO
Danaher’s Acquisition of GE’s BioPharma Business Results in the Creation of Cytiva
Hologic’s Second High-Throughput Molecular Assay for COVID-19 to be Unveiled
FDA Emergency Use Authorization Granted to Luminex for its ARIES® SARS-CoV-2 Assay
MilliporeSigma’s New CRISPR technology Given a US Patent
Mylab and Syngene Form Covid-19 Test Kits Production Pact
Mobidiag Received Emergency Use Authorization in Finland for Its Novodiag® COVID-19 Test
Second FDA Emergency Use Authorization, and CE Mark Received by the New BD COVID-19 Test
FDA Emergency Use Authorization for Seegene's Allplex™ 2019-nCoV Assay
Over 10 million tests of Allplex™ 2019-nCoV Assay Exported to Over 60 Nations Globally
Agendia Announces Publication of Study Validating Long Term Analytical Performance Characteristics of 80-Gene BluePrint® Molecular Subtyping Assay
InDRE Approves Sale of Co-Diagnostics' Logix Smart™ Coronavirus COVID-19 Test in Mexico
Promega GoTaq® Probe 1-Step RT-qPCR System Now in CDC COVID-19 Diagnostic Protocol for Emergency Use
Launch of Siemens Healthineers' Molecular FTD SARS-CoV-2 Assay Test Kit
Myriad's BRACAnalysis Diagnostic System Now Available to Assess HBOC Risk in Breast and Ovarian Cancer Patients
Launch of Qiagen's FDA-Approved therascreen® BRAF V600E RGQ PCR Kit as a Companion Diagnostic to BRAFTOVI®
CODX and Promega Collaborate on COVID-19 Test Kits Production
ELITechGroup and OSANG Secure FDA Emergency Use Authorization for COVID-19 Test Kits
Fosun Receives FDA Emergency Use Authorization COVID-19 RT-PCR Detection Kit
FDA Approval for Roche’s Cobas® HPV Test for Cervical Cancer
Bio-Rad Receives US FDA Approval for ddPCR COVID-19 Assay
Cepheid, Inc Receives Emergency Use Authorization (EUA) Policy Approval from U.S. FDA for Xpert® Xpress SARS-CoV-2 Diagnostic Test
CODX’s JV CoSara India to Manufacture RT-PCR COVID-19 Test Kits
CODX’s CE-IVD Logix Smart™ COVID-19 Test Kit Demand Surge
ELITechGroup Unveils GeneFinderTM COVID-19 Plus RealAmp Kit
Roche’s Cobas® SARS-CoV-2 Test Receives FDA Emergency Use Authorization
CINtec® PLUS Cytology Test from Roche Obtains FDA Approval
Roche Deploys 400K Coronavirus Test Kits to the U.S Hospitals and Laboratories
Thermo Scientific AcroMetrix COVID-19 RNA Control Now Available for Monitoring and Validating COVID-19 Molecular Diagnostic Tests
FDA Emergency Use Authorization and CE Mark for Qiagen's QIAstat-Dx Respiratory SARS-CoV-2 Panel Test
Critical Rise in the Global Production Capacity of Qiagen's RNA Extraction Kits to Detect Corona Virus
Release of Abbott ID NOW™ COVID-19 Test for Corona Virus Detection in Five Minutes
Launch of Abbott RealTime SARS-COV-2 EUA Test for Corona Virus Detection
Launch of BioMedomics' New Point-of-Care Serology Test to Detect Exposure to COVID-19
NuProbe and Qiagen Join Forces to Develop NGS-Based Cancer Diagnostic Tests for Non-Invasive Liquid Biopsy
US FDA Offers Emergency Use Authorization for bioMérieux' BIOFIRE® COVID-19 Test
bioMérieux Launched SARS-COV-2 R-GENE® Test
Emergency Use Authorization Requests Submitted by BD and BioGX for Use of New COVID-19 Tests in US
Qiagen to be Acquired by Thermo Fisher Scientific
CE Mark for VIASURE SARS-COV-2 RT-PCR Detection Kit Adapted for BD MAX™ System
GE’s Divestment of BioPharma Business to Danaher Completed
COVID-19 Diagnostic Testing Kit from Cytiva Launched
GenMark’s ePlex® SARS-CoV-2 Test Granted Emergency Use Authorization by the US FDA
GenMark Diagnostics’ ePlex® RUO Test Kits Commence Shipments Globally
FDA Emergency Use Authorization Given to Hologic’s Molecular Test for SARS-CoV-2
Hologic and LabCorp Granted US FDA’s COVID-19 Diagnostic Emergency Use Authorization
NxTAG® CoV Extended Panel from Luminex Granted FDA EUA
Hologic’s Scalable Versions of Panther System Introduced
Luminex’s VERIGENE® II Respiratory Flex Assay Submitted for FDA Clearance
Elypta’s Liquid Biopsy Kits to be Made by MilliporeSigma
Launch of Seegene's Allplex™ 2019-nCoV Assay in Korea
Bio-Rad Unveils EDX Respiratory Panel (RP) Positive Run Control for Molecular Assay Use
Bio-Rad Acquires Exact Diagnostics LLC
Cepheid and Sherlock Biosciences Collaborate on Developing Molecular Diagnostic Tests
FDA Approval for Cepheid’s Xpert® BCR-ABL Ultra Test
Roche to Expand its Diagnostics Business in South Africa
GE Healthcare’s Sera-Xtracta Isolation Kits for Cell-Free and Genomic DNA Introduced
Illumina and Roche Collaborate for Providing Greater Genomic Testing Access to Patients
Joint Development of Molecular Diagnostic Tests by SpeeDx and LabCorp
Launch of Qiagen Clinical Insights Precision Insights in Europe
ArcherDX to Co-Develop In-Vitro Diagnostic Tests with Illumina
FDA Approval for Myriad's BRACAnalysis CDx® Test for Use as a Companion Diagnostic for Lynparza® in Metastatic Pancreatic Cancer Patients having Germline BRCA Mutation
License Deal Signed by Promega to Access MilliporeSigma's Foundational CRISPR Genome-Editing Technology
Thermo Fisher Scientific to Launch Ion Torrent Oncomine Myeloid Research Assay to Simplify and Accelerate the Genomic Profiling Process
Codexis Agree to Provide Roche with High-Performance Molecular Diagnostic Enzyme
Roche Develops Cobas® Zika Blood Screening Test Kit
ELITechGroup, Inc Extends its Direct Sales and Customer Support Services in Canada
Exact Sciences and Genomic Health Merge
Japanese Regulatory Approval for Myriad's BRACAnalysis® Diagnostic System
Launch of Thermo Fisher Scientific's Ion Torrent Genexus System
Illumina and QIAGEN in a Partnership
Luminex’s ARIES® MRSA Assay Granted FDA 510(k) Clearance
FDA Approval for Myriad's myChoice® CDx Test for Use as a Companion Diagnostic for Zejula® in Late-line Ovarian Cancer Patients
Launch of Thermo Scientific Acrometrix BCR-ABL Panel
Roche Introduces Cobas® EBV and BKV Tests on the Cobas 6800/8800 Systems for Transplant Patients
Roche Receives U.S FDA Approval for Cobas® Babesia Test
US FDA Approved Thermo Fisher Scientific's ImmunoCAP Allergen Components test for Furry Animal for In Vitro Diagnostic Use
MilliporeSigma in an Agreement with Broad Institute
Exact Sciences’ New Laboratory Opens
Roche Molecular Shut Down its Production Site in California
Invisible Sentinel Acquired by bioMérieux
BD COR™ System Receives CE-IVDD Certification in Europe
Seegene to Broaden its Market Presence in Latin American IVD Market
Validation Studies of Agendia's MammaPrint® and BluePrint® Using RNA Next-Generation Sequencing Technology Published in the Journal of Molecular Diagnostics
Hologic’s Aptima® BV and Aptima® CV/TV Molecular Assays Cleared by US FDA
Agendia Joined Forces with Imegen for Exclusive Distribution of Breast Cancer Genomic Tests in Spain and Portugal
FDA Approval Qiagen's therascreen® PIK3CA RGQ PCR Kit as a Companion Diagnostic for Novartis' Piqray in Breast Cancer Patients
Cepheid Receives FDA Approval for Xpert® CT/NG Test
Roche Develops VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody
Roche Introduces Cobas® MTB-RIF/INH Test Used in Tuberculosis DNA Analysis
GenMark Diagnostics’ ePlex Blood Culture Identification Gram-Negative Panel Given FDA 510(k) Market Clearance
HTG Molecular and Illumina Expand Association
QIAGEN and LabCorp in a Partnership for the Former’s “Day-One” Program
Launch of Qiagen's Latest therascreen FGFR RGQ RT-PCR Kit in the US
Thermo Fisher Scientific Releases First-of-its-kind Commercial MicroED Solution
Thermo Fisher Scientific Join Forces with NX Prenatal to Develop Clinical Mass Spectrometry-Based Proteomics Assays
Opening of Wuxi NextCODE's New Genetic Analysis Laboratory in the United States
CE Mark for Abbott's Alinity™ m Diagnostics System and Assays
Two CE Marks for Aptima HIV-1 Quant Dx Assay from Hologic
Cytiva’s SeraSil-Mag Silica Particles Launched
Savyon Introduces Savvygen STI RT-PCR Assays for STI
USDA Grants a Contract to Bio-Rad In View of Pathogen Detection
Supply Contract Made by OncoDNA in Romania and Turkey
Release of Novel Molecular Diagnostics Test for TB by BD
Introduction of TruSightTM Oncology 500 by Illumina
Adoption of EdgeSeq Technology of HTG in IOR’s Genomics Hub
Major Stakes of Hain Lifescience Taken Over by Bruker
QIAGEN Join Forces with NeuMoDx to Provide NGS for Completely Incorporated MDx
Chinese Launch of MammaPrint and BluePrint of Agendia In Association with Genecast
Introduction of a Novel Real Time PCR Analysis Technology by Seegene
Commercial Release of OncoBEAM™ EGFR Kit v2 (RUO) in Europe and Asia by Sysmex
QIAGEN Extends Its Footprints In Africa By Collaborating With The Scientific Group
Admera Signs a Partnership Deal with Quadrant
Savyon is ready to Release Savvygen Lyophilized RT-PCR Assays for Stomach Flu
Rapid DNA Analysis Technology Offered by Thermo Fisher for Reassembling
Release of Ion AmpliSeq HD Technology by Thermo Fisher
Introduction of QIAseq 16S Panels and UCP Multiplex PCR kit by QIAGEN for Microbiome Profiling
Release of Novel Probes for In Situ Hybridization Protocols
Initiation of Clinical Studies of VERIGENE® II Gastrointestinal Assay by Luminex
MammaPrint and BluePrint of Agendia are Now Accessible in SouthEast Asia Via Angsana
Unicancer Adopts MammaPrint and BluePrint of Agendia in France
Expansion of Real-Time PCR assay Collection by R-Biopharm and ELITechGroup
Roche, DIAN and Foundation Medicine Join Forces to Enhance Chinese Tailored Cancer care
Expansion of In Situ Hybridization Probes Panel for Clinical Access by Agilent
Natera Join Forces with QIAGEN to Design Advanced Genetic Testing Assays
Introduction of Novel CE marked Assay by QIAGEN to Detect Trichomonas
Introduction of ccfDNA Blood Collection Tube by BD
Commercial Release of Oncotype DX® AR-V7 Nucleus Detect™ Test by Genomic Health
QIAGEN to Take Over STAT-Dx
Illumina Join Forces with KingMed to Design NGS Technology for CFDA Clearance
World’s Foremost Multiplex MDx Assay Designed by Seegene
Launch of Novel Salmonella Multiplex PCR Solution by Thermo Fisher
Agendia Alliance with Bluebee for Commercial Release of NGS-Based MammaPrint BluePrint
Co validation of MammaPrint BluePrint By Agendia and UZ Leuven Before EU Release
Agendia Alliances with Institut Curie to Co Validate MammaPrint BluePrint Breast Cancer kit
Release of NetSeqTM 550Dx System by Illumina
Extension of Respiratory Disease Panel by Cepheid
Launch of Custom Solutions Business by QIAGEN to Assist MDx and Life Science Firms
AutoGenomics Partners With LCM for Precision Medicine
Admera Extends its Existence in Asia through 3 Alliances
Release of riskScoreTM by Myriad to Detect Hereditary Cancer
Luminex and Sutter Join Forces To Offer Multiple Luminex Diagnostic Systems
Savyon Launches Multiplex Lyophilized RT-PCR Assays for Respiratory illness
HomeDNATM Now Accessible Throughout the Nation
Helix Collaborates With Admera to Offer Genetic Tests For Cardiology Related Ailments
European Launch of Real-Time PCR System for Clinical Diagnostics by Agilent
Agendia Collaborates With Agilent for Molecular Cancer Diagnostics
European Release of cobas® MRSA/SA test By Roche
Release of HTG EdgeSeq PATH Assay By HTG
Admera Alliances with University of Rochester to Evaluate Pharmacogenomics
Thermo Fisher and Seegene Partners to File for U.S FDA Clearance
Launch of Second Generation Real Time PCR Technology by Seegene
Instituto Valenciano de Oncología and HTG Partner to Assess Breast Cancer reappearance Risk
Launch of GenetiSure Dx Postnatal Assay By Agilent To Detect Genetic Anomalies
Multiplicom Completely Taken Over by Agilent
Seegene Unveils a Novel Normalization Software Technology for MDx
Adoption of ICE COLD-PCR of Transgenomic by LifeLabs
NAT Donor Screening Unit of Hologic Taken Over by Grifols

5. GLOBAL MARKET OVERVIEW
5.1 Global Molecular Diagnostics Market Overview by Technology
5.1.1 Molecular Diagnostics Technologies Market Overview by Global Region
5.1.1.1 PCR
5.1.1.2 Sequencing
5.1.1.3 Hybridization
5.1.1.4 Other Technologies
5.2 Global Molecular Diagnostics Market Overview by Product Type
5.2.1 Molecular Diagnostics Products Market Overview by Global Region
5.2.1.1 Reagents & Consumables
5.2.1.2 Instruments
5.2.1.3 Software & Services
5.3 Global Molecular Diagnostics Market Overview by Application
5.3.1 Molecular Diagnostics Applications Market Overview by Global Region
5.3.1.1 Infectious Diseases
5.3.1.2 Oncology
5.3.1.3 Blood Testing
5.3.1.4 Genetic Testing
5.3.1.5 Prenatal Testing
5.3.1.6 Other Applications
5.4 Global Molecular Diagnostics Market Overview by End-Use Sector
5.4.1 Molecular Diagnostics End User Market Overview by Global Region
5.4.1.1 Hospitals & Diagnostics Labs
5.4.1.2 Research Institutes & Universities
5.4.1.3 Other End-Use Sectors

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA
6.1 North American Molecular Diagnostics Market Overview by Geographic Region
6.2 North American Molecular Diagnostics Market Overview by Technology
6.2.1 Molecular Diagnostics Technologies Market Overview by NA Region
6.2.1.1 PCR
6.2.1.2 Sequencing
6.2.1.3 Hybridization
6.2.1.4 Other Technologies
6.3 North American Molecular Diagnostics Market Overview by Product Type
6.3.1 Molecular Diagnostics Products Market Overview by NA Region
6.3.1.1 Reagents & Consumables
6.3.1.2 Instruments
6.3.1.3 Software & Services
6.4 North American Molecular Diagnostics Market Overview by Applications
6.4.1 Molecular Diagnostics Applications Market Overview by NA Region
6.4.1.1 Infectious Diseases
6.4.1.2 Oncology
6.4.1.3 Blood Testing
6.4.1.4 Genetic Testing
6.4.1.5 Prenatal Testing
6.4.1.6 Other Applications
6.5 North American Molecular Diagnostics Market Overview by End-Use Sector
6.5.1 Molecular Diagnostics End-Use Sector Market Overview by NA Region
6.5.1.1 Hospitals & Diagnostics Labs
6.5.1.2 Research Institutes & Universities
6.5.1.3 Other End-User Sectors
6.6 Major Market Players

Abbott Diagnostics (United States)
Admera Health (United States)
Agilent Technologies, Inc. (United States)
Autogenomics, Inc. (United States)
Becton, Dickinson and Company (United States)
Bio-Rad Laboratories, Inc. (United States)
Danaher Corporation (United States)
Beckman coulter, Inc. (United States)
Cepheid (United States)
DNA diagnostics center (United States)
Exact Sciences Corporation (United States)
Foundation medicine (United States)
GenMark Diagnostics, Inc. (United States)
Global Life Sciences Solutions USA LLC (Cytiva) (United States)
Hologic, Inc. (United States)
HTG Molecular Diagnostics, Inc. (United States)
Illumina, Inc. (United States)
Laboratory Corporation of America ® Holdings (United States)
Luminex Corporation (United States)
Merck KGaA (Merck Millipore) (United States)
Myriad Genetics, Inc. (United States)
OriGene Technologies (United States)
Ortho Clinical Diagnostics (United States)
Pathogenetix, Inc. (United States)
PerkinElmer, Inc. (United States)
Promega Corporation (United States)
Sorenson Genomics, Inc. (United States)
Thermo Fisher Scientific, Inc. (United States)
Transgenomic, Inc. (United States)

6.7 Country-wise Analysis of North American Molecular Diagnostics Market
6.7.1 The United States
6.7.1.1 United States Molecular Diagnostics Market Overview by Technology
6.7.1.2 United States Molecular Diagnostics Market Overview by Product Type
6.7.1.3 United States Molecular Diagnostics Market Overview by Application
6.7.1.4 United States Molecular Diagnostics Market Overview by End-Use Sector
6.7.2 Canada
6.7.2.1 Canadian Molecular Diagnostics Market Overview by Technology
6.7.2.2 Canadian Molecular Diagnostics Market Overview by Product Type
6.7.2.3 Canadian Molecular Diagnostics Market Overview by Applications
6.7.2.4 Canadian Molecular Diagnostics Market Overview by End-Use Sector
6.7.3 Mexico
6.7.3.1 Mexican Molecular Diagnostics Market Overview by Technology
6.7.3.2 Mexican Molecular Diagnostics Market Overview by Product Type
6.7.3.3 Mexican Molecular Diagnostics Market Overview by Applications
6.7.3.4 Mexican Molecular Diagnostics Market Overview by End-Use Sector

7. EUROPE
7.1 European Molecular Diagnostics Market Overview by Geographic Region
7.2 European Molecular Diagnostics Market Overview by Technology
7.2.1 Molecular Diagnostics Technologies Market Overview by European Region
7.2.1.1 PCR
7.2.1.2 Sequencing
7.2.1.3 Hybridization
7.2.1.4 Other Technologies
7.3 European Molecular Diagnostics Market Overview by Product Type
7.3.1 Molecular Diagnostics Product Type Market Overview by European Region
7.3.1.1 Reagents & Consumables
7.3.1.2 Instruments
7.3.1.3 Software & Services
7.4 European Molecular Diagnostics Market Overview by Applications
7.4.1 Molecular Diagnostics Applications Market Overview by European Region
7.4.1.1 Infectious Diseases
7.4.1.2 Oncology
7.4.1.3 Blood Testing
7.4.1.4 Genetic Testing
7.4.1.5 Prenatal Testing
7.4.1.6 Other Applications
7.5 European Molecular Diagnostics Market Overview by End-Use Sector
7.5.1 Molecular Diagnostics End-Use Sector Market Overview by European Region
7.5.1.1 Hospitals & Diagnostics Labs
7.5.1.2 Research Institutes & Universities
7.5.1.3 Other End-Use Sectors
7.6 Major Market Players

Agendia NV (The Netherlands)
Analytik Jena (Germany)
BioMerieux SA (France)
ELITechGroup (France)
F. Hoffmann-La Roche AG (Switzerland)
Grifols International S.A (Spain)
Kaneka Eurogentec S.A (Belgium)
Oxford Gene Technology (The United Kingdom)
QIAGEN N.V. (The Netherlands)
Siemens Healthcare GmbH (Germany)
Sysmex Inostics GmbH (Germany)

7.7 Country-wise Analysis of European Molecular Diagnostics Market
7.7.1 Germany
7.7.1.1 German Molecular Diagnostics Market Overview by Technology
7.7.1.2 German Molecular Diagnostics Market Overview by Product Type
7.7.1.3 German Molecular Diagnostics Market Overview by Application
7.7.1.4 German Molecular Diagnostics Market Overview by End-Use Sector
7.7.2 France
7.7.2.1 French Molecular Diagnostics Market Overview by Technology
7.7.2.2 French Molecular Diagnostics Market Overview by Product Type
7.7.2.3 French Molecular Diagnostics Market Overview by Application
7.7.2.4 French Molecular Diagnostics Market Overview by End-Use Sector
7.7.3 The United Kingdom
7.7.3.1 United Kingdom Molecular Diagnostics Market Overview by Technology
7.7.3.2 United Kingdom Molecular Diagnostics Market Overview by Product Type
7.7.3.3 United Kingdom Molecular Diagnostics Market Overview by Application
7.7.3.4 United Kingdom Molecular Diagnostics Market Overview by End-Use Sector
7.7.4 Italy
7.7.4.1 Italian Molecular Diagnostics Market Overview by Technology
7.7.4.2 Italian Molecular Diagnostics Market Overview by Product Type
7.7.4.3 Italian Molecular Diagnostics Market Overview by Application
7.7.4.4 Italian Molecular Diagnostics Market Overview by End-Use Sector
7.7.5 Spain
7.7.5.1 Spanish Molecular Diagnostics Market Overview by Technology
7.7.5.2 Spanish Molecular Diagnostics Market Overview by Product Type
7.7.5.3 Spanish Molecular Diagnostics Market Overview by Application
7.7.5.4 Spanish Molecular Diagnostics Market Overview by End-Use Sector
7.7.6 Rest of Europe
7.7.6.1 Rest of Europe Molecular Diagnostics Market Overview by Technology
7.7.6.2 Rest of Europe Molecular Diagnostics Market Overview by Product Type
7.7.6.3 Rest of Europe Molecular Diagnostics Market Overview by Application
7.7.6.4 Rest of Europe Molecular Diagnostics Market Overview by End-Use Sector

8. ASIA-PACIFIC
8.1 Asia-Pacific Molecular Diagnostics Market Overview by Geographic Region
8.2 Asia-Pacific Molecular Diagnostics Market Overview by Technology
8.2.1 Molecular Diagnostics Technologies Market Overview by Asia-Pacific Region
8.2.1.1 PCR
8.2.1.2 Sequencing
8.2.1.3 Hybridization
8.2.1.4 Other Technologies
8.3 Asia-Pacific Molecular Diagnostics Market Overview by Product Type
8.3.1 Molecular Diagnostics Product Type Market Overview by Asia-Pacific Region
8.3.1.1 Reagents & Consumables
8.3.1.2 Instruments
8.3.1.3 Software & Services
8.4 Asia-Pacific Molecular Diagnostics Market Overview by Applications
8.4.1 Molecular Diagnostics Applications Market Overview by Asia-Pacific Region
8.4.1.1 Infectious Diseases
8.4.1.2 Oncology
8.4.1.3 Blood Testing
8.4.1.4 Genetic Testing
8.4.1.5 Prenatal Testing
8.4.1.6 Other Applications
8.5 Asia-Pacific Molecular Diagnostics Market Overview by End-Use Sector
8.5.1 Molecular Diagnostics End-Use Sector Market Overview by Asia-Pacific Region
8.5.1.1 Hospitals & Diagnostics Labs
8.5.1.2 Research Institutes & Universities
8.5.1.3 Other End-Use Sectors
8.6 Major Market Players

BGI-Shenzhen (China)
Dian Diagnostics Group Co., Ltd. (China)
Seegene, Inc. (South Korea)
Shanghai Runda Medical Technology Co., Ltd. (China)
WuXi NextCODE (China)

8.7 Country-wise Analysis of Asia-Pacific Molecular Diagnostics Market
8.7.1 China
8.7.1.1 Chinese Molecular Diagnostics Market Overview by Technology
8.7.1.2 Chinese Molecular Diagnostics Market Overview by Product Type
8.7.1.3 Chinese Molecular Diagnostics Market Overview by Application
8.7.1.4 Chinese Molecular Diagnostics Market Overview by End-Use Sector
8.7.2 Japan
8.7.2.1 Japanese Molecular Diagnostics Market Overview by Technology
8.7.2.2 Japanese Molecular Diagnostics Market Overview by Product Type
8.7.2.3 Japanese Molecular Diagnostics Market Overview by Application
8.7.2.4 Japanese Molecular Diagnostics Market Overview by End-Use Sector
8.7.3 India
8.7.3.1 Indian Molecular Diagnostics Market Overview by Technology
8.7.3.2 Indian Molecular Diagnostics Market Overview by Product Type
8.7.3.3 Indian Molecular Diagnostics Market Overview by Application
8.7.3.4 Indian Molecular Diagnostics Market Overview by End-Use Sector
8.7.4 South Korea
8.7.4.1 South Korean Molecular Diagnostics Market Overview by Technology
8.7.4.2 South Korean Molecular Diagnostics Market Overview by Product Type
8.7.4.3 South Korean Molecular Diagnostics Market Overview by Application
8.7.4.4 South Korean Molecular Diagnostics Market Overview by End-Use Sector
8.7.5 Rest of Asia-Pacific
8.7.5.1 Rest of Asia-Pacific Molecular Diagnostics Market Overview by Technology
8.7.5.2 Rest of Asia-Pacific Molecular Diagnostics Market Overview by Product Type
8.7.5.3 Rest of Asia-Pacific Molecular Diagnostics Market Overview by Application
8.7.5.4 Rest of Asia-Pacific Molecular Diagnostics Market Overview by End-Use Sector

9. REST OF WORLD
9.1 Rest of World Molecular Diagnostics Market Overview by Geographic Region
9.2 Rest of World Molecular Diagnostics Market Overview by Technology
9.2.1 Molecular Diagnostics Technologies Market Overview by RoW Region
9.2.1.1 PCR
9.2.1.2 Sequencing
9.2.1.3 Hybridization
9.2.1.4 Other Technologies
9.3 Rest of World Molecular Diagnostics Market Overview by Product Type
9.3.1 Molecular Diagnostics Product Type Market Overview by ROW Region
9.3.1.1 Reagents & Consumables
9.3.1.2 Instruments
9.3.1.3 Software & Services
9.4 Rest of World Molecular Diagnostics Market Overview by Applications
9.4.1 Molecular Diagnostics Applications Market Overview by ROW Region
9.4.1.1 Infectious Diseases
9.4.1.2 Oncology
9.4.1.3 Blood Testing
9.4.1.4 Genetic Testing
9.4.1.5 Prenatal Testing
9.4.1.6 Other Applications
9.5 Rest of World Molecular Diagnostics Market Overview by End-Use Sector
9.5.1 Molecular Diagnostics End-Use Sector Market Overview by ROW Region
9.5.1.1 Hospitals & Diagnostics Labs
9.5.1.2 Research Institutes & Universities
9.5.1.3 Other End-Use Sectors
9.6 Savyon Diagnostics (Israel) - A Major Market Player
9.7 Country-wise Analysis of Rest of World Molecular Diagnostics Market
9.7.1 Brazil
9.7.1.1 Brazilian Molecular Diagnostics Market Overview by Technology
9.7.1.2 Brazilian Molecular Diagnostics Market Overview by Product Type
9.7.1.3 Brazilian Molecular Diagnostics Market Overview by Application
9.7.1.4 Brazilian Molecular Diagnostics Market Overview by End-Use Sector
9.7.2 Argentina
9.7.2.1 Argentinean Molecular Diagnostics Market Overview by Technology
9.7.2.2 Argentinean Molecular Diagnostics Market Overview by Product Type
9.7.2.3 Argentinean Molecular Diagnostics Market Overview by Application
9.7.2.4 Argentinean Molecular Diagnostics Market Overview by End-Use Sector
9.7.3 Israel
9.7.3.1 Israeli Molecular Diagnostics Market Overview by Technology
9.7.3.2 Israeli Molecular Diagnostics Market Overview by Product Type
9.7.3.3 Israeli Molecular Diagnostics Market Overview by Application
9.7.3.4 Israeli Molecular Diagnostics Market Overview by End-Use Sector
9.7.4 Other ROW Countries
9.7.4.1 Other ROW Countries Molecular Diagnostics Market Overview by Technology
9.7.4.2 Other ROW Countries Molecular Diagnostics Market Overview by Product Type
9.7.4.3 Other ROW Countries Molecular Diagnostics Market Overview by Application
9.7.4.4 Other ROW Countries Molecular Diagnostics Market Overview by End-Use Sector

PART C: GUIDE TO THE INDUSTRY
1. North America
2. Europe
3. Asia-Pacific
4. Rest of World

PART D: ANNEXURE
1. Research Methodology
2. Feedback

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Molecular Diagnostics Market (2019, 2022 & 2026) by Application
Chart 2: Global Molecular Diagnostics Market (2019, 2022 & 2026) by Technology
Chart 3: Global Molecular Diagnostics Market (2019, 2022 & 2026) by End-Use Sector
Chart 4: Global Molecular Diagnostics Market (2019, 2022 & 2026) by Product Type
Chart 5: Global Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 6: Global Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 7: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 8: Global Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 9: Glance at 2017, 2019 and 2026 Global Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 10: Global Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 11: Glance at 2017, 2019 and 2026 Global Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 12: Global Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 13: Glance at 2017, 2019 and 2026 Global Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 14: Global Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 15: Glance at 2017, 2019 and 2026 Global Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 16: Global Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 17: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 18: Global Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 19: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 20: Global Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 21: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Instruments Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 22: Global Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 23: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 24: Global Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 25: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 26: Global Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 27: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 28: Global Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 29: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 30: Global Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 31: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 32: Global Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 33: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 34: Global Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 35: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 36: Global Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 37: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 38: Global Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 39: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
Chart 40: Global Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 41: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 42: Global Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 43: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
Chart 44: Global Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 45: Glance at 2017, 2019 and 2026 Global Market Share (%) for Molecular Diagnostics in Other End Users by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE
Chart 46: Global Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
Chart 47: Glance at 2017, 2019 and 2026 Global Molecular Diagnostics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA
Chart 48: North American Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 49: North American Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 50: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 51: North American Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 52: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 53: North American Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
Chart 54: Glance at 2017, 2019 and 2026 North American Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
Chart 55: North American Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
Chart 56: Glance at 2017, 2019 and 2026 North American Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
Chart 57: North American Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
Chart 58: Glance at 2017, 2019 and 2026 North American Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
Chart 59: North American Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico in USD Million
Chart 60: Glance at 2017, 2019 and 2026 North American Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - United States, Canada and Mexico
Chart 61: North American Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 62: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 63: North American Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 64: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 65: North American Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 66: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Instruments Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 67: North American Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - United States, Canada and Mexico in USD Million
Chart 68: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - United States, Canada and Mexico
Chart 69: North American Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 70: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 71: North American Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - United States, Canada and Mexico in USD Million
Chart 72: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - United States, Canada and Mexico
Chart 73: North American Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - United States, Canada and Mexico in USD Million
Chart 74: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - United States, Canada and Mexico
Chart 75: North American Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - United States, Canada and Mexico in USD Million
Chart 76: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - United States, Canada and Mexico
Chart 77: North American Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - United States, Canada, and Mexico in USD Million
Chart 78: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - United States, Canada and Mexico
Chart 79: North American Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - United States, Canada and Mexico in USD Million
Chart 80: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - United States, Canada and Mexico
Chart 81: North American Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - United States, Canada and Mexico in USD Million
Chart 82: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - United States, Canada and Mexico
Chart 83: North American Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 84: Glance at 2017, 2019 and 2026 North American Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
Chart 85: North American Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - United States, Canada and Mexico in USD Million
Chart 86: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - United States, Canada and Mexico
Chart 87: North American Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - United States, Canada and Mexico in USD Million
Chart 88: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - United States, Canada and Mexico
Chart 89: North American Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - United States, Canada and Mexico in USD Million
Chart 90: Glance at 2017, 2019 and 2026 North American Market Share (%) for Molecular Diagnostics in Other End-User Sectors by Geographic Region - United States, Canada and Mexico

The United States
Chart 91: United States Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 92: United States Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 93: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 94: United States Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 95: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 96: United States Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 97: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 98: United States Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 99: Glance at 2017, 2019 and 2026 United States Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Canada
Chart 100: Canadian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 101: Canadian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 102: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 103: Canadian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 104: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 105: Canadian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 106: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 107: Canadian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 108: Glance at 2017, 2019 and 2026 Canadian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Mexico
Chart 109: Mexican Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 110: Mexican Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 111: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 112: Mexican Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 113: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 114: Mexican Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 115: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 116: Mexican Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 117: Glance at 2017, 2019 and 2026 Mexican Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

EUROPE
Chart 118: European Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 119: European Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 120: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 121: European Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 122: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 123: European Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 124: Glance at 2017, 2019 and 2026 European Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 125: European Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 126: Glance at 2017, 2019 and 2026 European Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 127: European Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 128: Glance at 2017, 2019 and 2026 European Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 129: European Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 130: Glance at 2017, 2019 and 2026 European Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 131: European Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 132: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 133: European Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 134: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 135: European Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 136: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Instruments Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 137: European Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 138: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 139: European Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 140: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 141: European Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 142: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 143: European Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 144: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 145: European Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 146: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 147: European Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 148: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 149: European Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 150: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 151: European Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 152: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 153: European Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 154: Glance at 2017, 2019 and 2026 European Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
Chart 155: European Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 156: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 157: European Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 158: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe
Chart 159: European Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe in USD Million
Chart 160: Glance at 2017, 2019 and 2026 European Market Share (%) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - Germany, France, United Kingdom, Italy, Spain and Rest of Europe

Germany
Chart 161: German Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 162: German Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 163: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 164: German Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 165: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 166: German Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 167: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 168: German Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 169: Glance at 2017, 2019 and 2026 German Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

France
Chart 170: French Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 171: French Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 172: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 173: French Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 174: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 175: French Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 176: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 177: French Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 178: Glance at 2017, 2019 and 2026 French Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

The United Kingdom
Chart 179: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 180: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 181: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 182: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 183: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 184: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 185: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 186: United Kingdom Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 187: Glance at 2017, 2019 and 2026 United Kingdom Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Italy
Chart 188: Italian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 189: Italian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 190: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 191: Italian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 192: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 193: Italian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 194: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 195: Italian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 196: Glance at 2017, 2019 and 2026 Italian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Spain
Chart 197: Spanish Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 198: Spanish Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 199: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 200: Spanish Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 201: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 202: Spanish Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 203: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 204: Spanish Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 205: Glance at 2017, 2019 and 2026 Spanish Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Rest of Europe
Chart 206: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 207: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 208: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 209: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 210: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 211: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 212: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 213: Rest of Europe Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 214: Glance at 2017, 2019 and 2026 Rest of Europe Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

ASIA-PACIFIC
Chart 215: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 216: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 217: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 218: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 219: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 220: Asia-Pacific Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 221: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 222: Asia-Pacific Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 223: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 224: Asia-Pacific Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 225: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 226: Asia-Pacific Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 227: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 228: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 229: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 230: Asia-Pacific Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 231: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 232: Asia-Pacific Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 233: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Instruments Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 234: Asia-Pacific Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 235: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 236: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 237: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 238: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 239: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 240: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 241: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 242: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 243: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 244: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 245: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 246: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 247: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 248: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 249: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 250: Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 251: Glance at 2017, 2019 and 2026 Asia-Pacific Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
Chart 252: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 253: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 254: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 255: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific
Chart 256: Asia-Pacific Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific in USD Million
Chart 257: Glance at 2017, 2019 and 2026 Asia-Pacific Market Share (%) for Molecular Diagnostics in Other End-Use Sector by Geographic Region - China, Japan, India, South Korea and Rest of Asia-Pacific

China
Chart 258: Chinese Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 259: Chinese Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 260: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 261: Chinese Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 262: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 263: Chinese Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 264: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 265: Chinese Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 266: Glance at 2017, 2019 and 2026 Chinese Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Japan
Chart 267: Japanese Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 268: Japanese Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 269: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 270: Japanese Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 271: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 272: Japanese Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 273: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 274: Japanese Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 275: Glance at 2017, 2019 and 2026 Japanese Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

India
Chart 276: Indian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 277: Indian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 278: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 279: Indian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 280: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 281: Indian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 282: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 283: Indian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 284: Glance at 2017, 2019 and 2026 Indian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

South Korea
Chart 285: South Korean Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 286: South Korean Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 287: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 288: South Korean Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 289: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 290: South Korean Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 291: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 292: South Korean Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 293: Glance at 2017, 2019 and 2026 South Korean Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Rest of Asia-Pacific
Chart 294: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 295: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 296: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 297: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 298: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 299: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 300: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 301: Rest of Asia-Pacific Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 302: Glance at 2017, 2019 and 2026 Rest of Asia-Pacific Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

REST OF WORLD
Chart 303: Rest of World Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 304: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 305: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 306: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 307: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 308: Rest of World Market Analysis (2017-2026) for PCR in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 309: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for PCR in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 310: Rest of World Market Analysis (2017-2026) for Sequencing in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 311: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Sequencing in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 312: Rest of World Market Analysis (2017-2026) for Hybridization in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 313: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Hybridization in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 314: Rest of World Market Analysis (2017-2026) for Other Technologies in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 315: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Other Technologies in Molecular Diagnostics by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 316: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 317: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 318: Rest of World Molecular Diagnostics Reagents & Consumables Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 319: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Reagents & Consumables Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 320: Rest of World Molecular Diagnostics Instruments Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 321: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Instruments Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 322: Rest of World Molecular Diagnostics Software & Services Market Analysis (2017-2026) by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 323: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Software & Services Market Share (%) by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 324: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 325: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 326: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 327: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Infectious Diseases by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 328: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Oncology by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 329: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Oncology by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 330: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Blood Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 331: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Blood Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 332: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Genetic Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 333: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Genetic Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 334: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 335: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Prenatal Testing by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 336: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Other Applications by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 337: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Other Applications by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 338: Rest of World Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 339: Glance at 2017, 2019 and 2026 Rest of World Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other
Chart 340: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 341: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Hospitals & Diagnostics Labs by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 342: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 343: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Research Institutes & Universities by Geographic Region - Brazil, Argentina, Israel and Other Countries
Chart 344: Rest of World Market Analysis (2017-2026) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - Brazil, Argentina, Israel and Other Countries in USD Million
Chart 345: Glance at 2017, 2019 and 2026 Rest of World Market Share (%) for Molecular Diagnostics in Other End-Use Sectors by Geographic Region - Brazil, Argentina, Israel and Other Countries

Brazil
Chart 346: Brazilian Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 347: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 348: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 349: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 350: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 351: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 352: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 353: Brazilian Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 354: Glance at 2017, 2019 and 2026 Brazilian Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Argentina
Chart 355: Argentinean Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 356: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 357: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 358: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 359: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 360: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 361: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 362: Argentinean Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 363: Glance at 2017, 2019 and 2026 Argentinean Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Israel
Chart 364: Israeli Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 365: Israeli Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 366: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 367: Israeli Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 368: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 369: Israeli Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 370: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 371: Israeli Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 372: Glance at 2017, 2019 and 2026 Israeli Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Other ROW Countries
Chart 373: Other Countries Molecular Diagnostics Market Analysis (2017-2026) in USD Million
Chart 374: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by Technology - PCR, Sequencing, Hybridization and Other in USD Million
Chart 375: Glance at 2017, 2019 and 2026 Other ROW Countries Molecular Diagnostics Market Share (%) by Technology - PCR, Sequencing, Hybridization and Other
Chart 376: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by Product - Reagents & Consumables, Instruments and Software & Services in USD Million
Chart 377: Glance at 2017, 2019 and 2026 Other ROW Countries Molecular Diagnostics Market Share (%) by Product - Reagents & Consumables, Instruments and Software & Services
Chart 378: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other in USD Million
Chart 379: Glance at 2017, 2019 and 2026 Other RoW Countries Molecular Diagnostics Market Share (%) by Application - Infectious Diseases, Oncology, Blood Testing, Genetic Testing, Prenatal Testing and Other
Chart 380: Other ROW Countries Molecular Diagnostics Market Analysis (2017-2026) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other in USD Million
Chart 381: Glance at 2017, 2019 and 2026 Other ROW Countries Molecular Diagnostics Market Share (%) by End-Use Sector - Hospitals & Diagnostics Labs, Research Institutes & Universities and Other

Tables:
Table 1: Nanotechnologies and Its Uses in Molecular Diagnostics
Table 2: Most Recent Molecular Diagnostic Product Approvals
Table 3: List of some popular Infectious diseases and its Particulars

Samples

LOADING...

Companies Mentioned

Abbott Diagnostics
Admera Health
Agendia NV
Agilent Technologies, Inc.
Analytik Jena
Autogenomics, Inc.
Beckman coulter, Inc.
Becton, Dickinson and Company
BGI-Shenzhen
Bio-Rad Laboratories, Inc.
BioMerieux SA
Cepheid
Danaher Corporation
Dian Diagnostics Group Co., Ltd.
DNA diagnostics center
Elitechgroup
Exact Sciences Corporation
F. Hoffmann-La Roche Ag
Foundation medicine
Genmark Diagnostics, Inc.
Global Life Sciences Solutions USA LLC (Cytiva)
Grifols International S.A
Hologic, Inc.
HTG Molecular Diagnostics, Inc.
Illumina, Inc.
Kaneka Eurogentec S.A
Laboratory Corporation of America® Holdings
Luminex Corporation
Merck KGaA (Merck Millipore)
Myriad Genetics, Inc.
OriGene Technologies
Ortho Clinical Diagnostics
Oxford Gene Technology
Pathogenetix, Inc.
PerkinElmer, Inc.
Promega Corporation
Qiagen N.V.
Savyon Diagnostics
Seegene Inc.
Shanghai Runda Medical Technology Co., Ltd.
Siemens Healthcare GmbH
Sorenson Genomics, LLC
Sysmex Inostics GmbH
Thermo Fisher Scientific Inc.
Transgenomic Inc.
Wuxi Nextcode

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4729EUR$4,860USD£4,051GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7356EUR$7,560USD£6,301GBP

Table of Contents

Samples

Companies Mentioned

Related Topics

Related Reports

Molecular Diagnostics - Global Strategic Business Report

U.S. Molecular Diagnostics Market Size, Share & Trends Analysis Report By Disease (Healthcare-associated Infections, Respiratory), By End-use (Hospital Core Laboratory, Decentralized Test Sites), And Segment Forecasts, 2023 - 2030

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030

Molecular Diagnostics

The World Market for Molecular Diagnostics, 12th Edition